Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
81
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US

Krithika Rajagopalan1 Sunovion Pharmaceuticals Inc., Marlborough, MA 01752, USA, [email protected]
,
Lisa Bloudek2 Curta Inc., Seattle, WA 98116, USA
,
Jessica Marvel3 Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA
,
Carole Dembek1 Sunovion Pharmaceuticals Inc., Marlborough, MA 01752, USA, [email protected]Correspondence[email protected]
&
Abhishek Kavati3 Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA
Pages 3867-3877 | Published online: 28 Nov 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Erik J Groessl, Steven R Tally & Naomi Hillery. (2023) Cost-Effectiveness of Humidified High-Flow Therapy (HHFT) for COPD Patients on Long-Term Oxygen Therapy. ClinicoEconomics and Outcomes Research 15, pages 239-250.
Read now
Ying Lan, Nan Yang, Yirong Wang, Yujie Yang, Min Xu & Qin He. (2022) Cost-Effectiveness of Umeclidinium/Vilanterol versus Salmeterol/Fluticasone in Elderly Patients with Chronic Obstructive Pulmonary Diseases in China. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 609-619.
Read now
Shiyi Gong, Hao Hu, Kun Zhao & Ting Yang. (2021) Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 433-441.
Read now
Aysegül Aksan, Ian L P Beales, Garth Baxter, Antonio Ramirez de Arellano, Simona Gavata, William J Valentine & Barnaby Hunt. (2021) Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK. ClinicoEconomics and Outcomes Research 13, pages 541-552.
Read now
Tanja Fens, Guiling Zhou, Maarten J. Postma, Eugène P. van Puijenbroek & Job F.M. van Boven. (2021) Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?. Expert Opinion on Pharmacotherapy 22:7, pages 923-935.
Read now

Articles from other publishers (3)

James Hall, Alice Margaret Turner, Janine Dretzke, David Moore & Sue Jowett. (2022) Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease. Thorax 77:10, pages 976-986.
Crossref
Jia Liu, Xiaoning He & Jing Wu. (2022) Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model. Applied Health Economics and Health Policy 20:5, pages 743-755.
Crossref
Aysegül Aksan, Alain Schoepfer, Pascal Juillerat, Stephan Vavricka, Miguel Bettencourt, Antonio Ramirez de Arellano, Simona Gavata, Neige Morin, William J. Valentine & Barnaby Hunt. (2020) Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland. Advances in Therapy 38:1, pages 660-677.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.